Top-News

GSK Glaxo Smith Kline Aktie (ADR) News

Aktie
WKN:  A3DMHS ISIN:  US37733W2044 US-Symbol:  GSK Branche:  Pharmazeutika Land:  Großbritannien
41,40 €
-0,3 €
-0,72%
05.12.25
Depot/Watchlist
Marktkapitalisierung *
82,88 Mrd. €
Streubesitz
80,80%
KGV
21,77
Dividende
0,42 $
Dividendenrendite
0,86%
Faktor
0.5
Originalaktie
GB00BN7SWP63

GSK Glaxo Smith Kline Aktie (ADR) News

28.03.25 - PR Newswire
GSK Deadline: GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
GSK Deadline: GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit PR Newswire
28.03.25 - PR Newswire
Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)
Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK) PR Newswire
27.03.25 - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK PR Newswire
26.03.25 - PR Newswire
ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program
ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-​Exposure Prophylaxis (PrEP) under the Non-​Insured Health Benefits (NIHB) Program Canada NewsWire
25.03.25 - PR Newswire
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
25.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK PR Newswire
25.03.25 - PR Newswire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
24.03.25 - PR Newswire
Class Action Filed Against GSK plc (GSK) - April 7, 2025 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against GSK plc (GSK) - April 7, 2025 Deadline to Join - Contact The Gross Law Firm PR Newswire
23.03.25 - PR Newswire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit PR Newswire
21.03.25 - PR Newswire
GSK LAWSUIT ALERT: Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline
GSK LAWSUIT ALERT: Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
20.03.25 - PR Newswire
GSK plc Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - GSK
GSK plc Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - GSK PR Newswire
19.03.25 - PR Newswire
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
18.03.25 - PR Newswire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit PR Newswire
18.03.25 - PR Newswire
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
18.03.25 - PR Newswire
Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline - GSK
Levi & Korsinsky Notifies GSK plc Investors of a Class Action Lawsuit and Upcoming Deadline - GSK PR Newswire
17.03.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK PR Newswire
17.03.25 - PR Newswire
The Gross Law Firm Reminds GSK plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSK
The Gross Law Firm Reminds GSK plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSK PR Newswire
13.03.25 - PR Newswire
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit PR Newswire
13.03.25 - PR Newswire
GSK plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - GSK
GSK plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - GSK PR Newswire
11.03.25 - PR Newswire
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
GSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »